Sierra Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Sierra Capital’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26	Closed	–	–	874
2021 Q4	$0	Buy	+26	New	–	﹤0.01%	897

Other funds holding ALXN

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

Sierra Capital's ALXN Position: Q1 2022 in Review

Sierra Capital sold out of Alexion Pharmaceuticals (ALXN) in Q1 2022, closing a stake of 26 shares.

Sierra Capital first reported a position in ALXN in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 1 fund tracked by Wall St. Rank holds ALXN as of Q1 2022.

Sierra Capital reported no remaining Alexion Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Sierra Capital sold 26 Alexion Pharmaceuticals shares in Q1 2022.
Sierra Capital first reported a position in Alexion Pharmaceuticals in Q4 2021 and held it in 1 quarter.
Sierra Capital's Alexion Pharmaceuticals position peaked at $0 in Q4 2021.
1 fund tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2022.

Based on Sierra Capital's 13F filing for Q1 2022, filed 3 May 2022.